secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kymera Therapeutics, Inc. (KYMR)
CIK:        0001815442
Form:       8-K
Filed at:   2026-06-24T20:07:58+00:00
Accession:  0001193125-26-281051
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Kymera annual meeting results: all Class III directors elected, say-on-pay approved, EY ratified
--------------------------------------------------------------------------------

- Elected Bruce Booth, Nello Mainolfi, John Maraganore, Elena Ridloff as Class III directors for 3-year terms.
- Advisory vote on named executive officer compensation passed with 74.9M for, 2.5M against, 26.6K abstain.
- Ratified Ernst & Young as independent auditor for FY2026 with 79.0M for, 38.1K against, 18.2K abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815442/000119312526281051/0001193125-26-281051-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815442/000119312526281051/d131538d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-281051

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer